Examine the Russian Pharmaceuticals and Healthcare Industry with this Essential Report, Q3 2008.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/ee6c23/russia_pharmaceuti) has announced the addition of the "Russia Pharmaceuticals and Healthcare Report Q3 2008" report to their offering. The Russia Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Russia's pharmaceuticals and healthcare industry. Beginning this quarter, BMI BMI body mass index. BMI abbr. body mass index Body mass index (BMI) A measurement that has replaced weight as the preferred determinant of obesity. introduces a new and improved forecasting methodology. This, along strong Q108 results reported by local market research agencies, has led us to substantially upgrade our growth forecast for 2008 for the total pharmaceutical to 24% year-on-year (y-o-y). For the period 2008-2012, we forecast average annual growth of 13.8% in US dollar terms and 10.5% in local currency terms. As BMI's recently launched Burden of Disease Database underlines, Russia faces a greater disease burden than any other European country. The government has a major opportunity to address this crisis under ambitious plans to expand medicines provision and revive To renew. For example, revival is the act of renewing the legal force of a contract or debt, either by acknowledging it or by giving a new promise, when the contract or debt is no longer a sufficient foundation for a lawsuit because it is barred by the running of the Statute the pharmaceutical industry. Implementation, however, will remain the biggest challenge. In June, Prime Minister Vladimir Putin announced plans for the launch of a mandatory medicines insurance scheme with state subsidies, to be launched in 2010. These mechanisms will in turn provide funding for a new and comprehensive medicines provision programme. Putin's statements represent the most detailed public elaboration of plans that have been under discussion for several months now. The programme is due to be launched in 2010. Some 18 months is a long time in Russian politics and the real test will be to see if the government puts in place effective mechanisms to weed weed, common term for any wild plant, particularly an undesired plant, growing in cultivated ground, where it competes with crop plants for soil nutrients and water. out graft graft, in surgery: see transplantation, medical. graft In horticulture, the act of placing a portion of one plant (called a bud or scion) into or on a stem, root, or branch of another (called the stock) in such a way that a union forms and the and waste, two problems that saw the DLO DLO abbr. dead letter office DLO n abbr (= dead-letter office) → oficina de Correos que se encarga de las cartas que no llegan a su destino supplementary medicines scheme blow up spectacularly in 2007. The new medicines insurance scheme is also intended as a vehicle for reviving re·vive v. re·vived, re·viv·ing, re·vives v.tr. 1. To bring back to life or consciousness; resuscitate. 2. To impart new health, vigor, or spirit to. 3. the domestic pharmaceutical industry, which now accounts for just 25% of sales in value terms. More generally, the government would like to see the State Pharmaceutical Holding, a diverse group of research institutes and generally small manufacturers, take on important substitution Substitution Arsinoë put her own son in place of Orestes; her son was killed and Orestes was saved. [Gk. Myth.: Zimmerman, 32] Barabbas robber freed in Christ’s stead. [N.T.: Matthew 27:15–18; Swed. Lit. duties in areas such as vaccines, hormones Hormones Chemicals produced by glands in the body that circulate in the blood and control the actions of cells and organs. Estrogens are hormones that affect breast cancer growth. Mentioned in: Breast Cancer, Hypoparathyroidism and other segments where Russia (and the Soviet Union) was previously strong. But the much discussed 'blueprint' for the pharmaceutical industry, outlined by Health Minister Tatiana Golikova Tatiana Alekseyevna Golikova (Russian: Татья́на Алексе́евна Го́ликова; born 9 February 1966 in Mytishchi) is a on the same day as Putin's medicines insurance initiative, remains vague about what do with Russia's myriad Myriad is a classical Greek name for the number 104 = 10 000. In modern English the word refers to an unspecified large quantity. The term myriad is a progression in the commonly used system of describing numbers using tens and hundreds. smaller, regional producers as well as some dodgier larger makers of copy drugs. Medicines prices are emerging as a stick with which to beat international drugmakers as well as a major headache headache Pain in the upper portion of the head. Episodic tension headaches are the most common, usually causing mild to moderate pain on both sides. They result from sustained contraction of face and neck muscles, often due to fatigue, stress, or frustration. for the government as it aims to tame inflation driven by record high food prices. The country's Audit Chamber reported in June that 'baseless' increases in the price of imported medicines had cost the state around RUR3bn (US$117mn) in 2006 and 2007, with 90% of state purchases going to imported medicines. The auditor criticised the lack of a single pricing regulation for state purchases. It perhaps this level of political uncertainty - and the high price of existing assets - that has slowed the tide of M&A and new market entries in Russia. In one recent move, Pfizer, the number sixth player in 2007, opened its own warehouse and launched its own operating subsidiary An operating subsidiary is a business term frequently used within the United States railroad industry. In the case of a railroad, it refers to a company that is a subsidiary but operates with its own identity and rolling stock. in the country in May. But activity in the wholesale and retail market may slow as the Russian Federal Anti-Monopoly Service (FAS) probes concentration in the sector and new retail restrictions are on the table. Russia remains a difficult market, with the threat of government intervention A procedure used in a lawsuit by which the court allows a third person who was not originally a party to the suit to become a party, by joining with either the plaintiff or the defendant. on the horizon. Key Topics Covered: -Executive Summary -Russia Pharmaceuticals And Healthcare Industry SWOT -Russia Political SWOT -Russia Economic SWOT -Russia Business Environment SWOT -Pharmaceutical Business Environment Ratings -Limits Of Potential Returns -Risk To Realisation Of Returns -Russia - Market Summary -Medical Devices -Regulatory Regime -Intellectual Property Environment -Pricing And Reimbursement Issues -Industry Developments -Industry Forecast Scenario -Overall Market Forecast -Key Growth Factors - Industry -Key Growth Factors - Macroeconomic -Russia - Economic Activity -Prescription Market Forecast -OTC Market Forecast -Generics Market Forecast -Export/Import Forecasts -Other Healthcare Data Forecasts -Key Risks To BMI's Forecast Scenario -Competitive Landscape -Manufacturing Sector -Wholesale Sector -Retail Sector -Company Monitor -Berlin-Chemie/Menarini Pharma GmbH -Gedeon Richter -Krka -Lek (Novartis/Sandoz) -Stada AG/Nizhpharm -Verofarm -BMI Forecast Modelling -How We Generate Our Pharmaceutical Industry Forecasts -Pharmaceutical Industry -Pharmaceutical Business Environment Ratings Methodology -Ratings Overview -Weighting -Sources Companies Mentioned: -Berlin-Chemie/Menarini Pharma GmbH -Gedeon Richter -Krka -Lek (Novartis/Sandoz) -Stada AG/Nizhpharm -Verofarm For more information visit http://www.researchandmarkets.com/research/ee6c23/russia_pharmaceuti |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion